Literature DB >> 31175917

Clear cell papillary renal cell carcinoma: molecular profile and virtual karyotype.

Diana M Morlote1, Shuko Harada2, Denise Batista3, Jennifer Gordetsky4, Soroush Rais-Bahrami5.   

Abstract

Clear cell papillary renal cell carcinoma (CCP-RCC) is a recently recognized tumor that shares morphologic features of both clear cell renal cell carcinoma and papillary renal cell carcinoma but behaves in a more indolent fashion. To date, there is little molecular information available on CCP-RCC. DNA was extracted from formalin-fixed, paraffin-embedded tissue blocks of 22 cases of CCP-RCC at the University of Alabama at Birmingham. Targeted next-generation sequencing and single-nucleotide polymorphism array were performed on all cases. Next-generation sequencing analysis found 30 somatic variants across 63.3% of cases. Seventeen variants (56.7%) were predicted to be deleterious or possibly/probably damaging. Single-nucleotide polymorphism array analysis found copy number abnormalities and/or loss of heterozygosity in 22.7% of cases. We analyzed the genetic characteristics of a group of CCP-RCCs cases and found them to be genetically different from one another. Some cases were genetically similar to clear cell renal cell carcinoma.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clear cell papillary renal cell carcinoma; Genetic profile; Low-grade renal cell carcinoma; Molecular study; VHL mutations; Virtual karyotyping

Mesh:

Year:  2019        PMID: 31175917     DOI: 10.1016/j.humpath.2019.05.011

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

2.  Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells.

Authors:  Iris E Glykofridis; Jaco C Knol; Jesper A Balk; Denise Westland; Thang V Pham; Sander R Piersma; Sinéad M Lougheed; Sepide Derakhshan; Puck Veen; Martin A Rooimans; Saskia E van Mil; Franziska Böttger; Pino J Poddighe; Irma van de Beek; Jarno Drost; Fried Jt Zwartkruis; Renee X de Menezes; Hanne Ej Meijers-Heijboer; Arjan C Houweling; Connie R Jimenez; Rob Mf Wolthuis
Journal:  Elife       Date:  2021-01-18       Impact factor: 8.140

Review 3.  Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC).

Authors:  Jacek Rysz; Beata Franczyk; Janusz Ławiński; Anna Gluba-Brzózka
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

4.  Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.

Authors:  Xi Tian; Wen-Hao Xu; Jun-Long Wu; Hua-Lei Gan; Hong-Kai Wang; Wei-Jie Gu; Yuan-Yuan Qu; Hai-Liang Zhang; Ding-Wei Ye
Journal:  Pathol Oncol Res       Date:  2021-08-27       Impact factor: 3.201

Review 5.  Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update.

Authors:  Ziad M El-Zaatari; Luan D Truong
Journal:  Biomedicines       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.